Literature DB >> 15694809

Dysregulated apoptosis in primary varicose veins.

E Ducasse1, K Giannakakis, J Chevalier, D Dasnoy, P Puppinck, F Speziale, P Fiorani, T Faraggiana.   

Abstract

OBJECTIVE: Programmed cell death plays a critical role in various physiological processes. To investigate its possible pathogenic role in primary varicose veins we studied histological changes in surgical specimens from human varicose veins. In varicose and healthy veins, we also determined the number of cells in apoptosis, and investigated mediators regulating the intrinsic apoptotic mitochondrial pathway (Bax and caspase 9).
METHODS: A total 23 varicose veins were obtained from 18 patients undergoing lower-extremity varicose vein surgery for primary varicose disorders. We used nine healthy veins obtained from nine patients undergoing distal arterial bypass grafting surgery as controls. The venous segment analysed was the distal part of the greater saphenous vein. Specimens for histological examination were stained with hematoxylin and eosin, trichromic and Victoria blue. Cell apoptoses and mediators of the mitochondrial pathway were detected in the media by immunohistochemistry using antibodies to peroxidase in situ apoptosis, Bax and caspase 9. Results were expressed as indexes for the three antibodies tested. The Mann-Whitney test was used to compare the results obtained in the two groups.
RESULTS: Varicose vein specimens exhibited a more disorganised architecture than healthy veins and showed an increased number of collagen fibres and a decrease in the density and size of elastic fibres. All anti-apoptotic antibodies tested detected significantly fewer immunoreactive cells in tissue sections from the media of varicose veins than of healthy veins (peroxidase in situ, varicose veins (VV) median 2.4% (inter-quartile range 1.6-3.9) versus control (C) 14% (IQR 8.8-19); Bax, VV 1.4% (IQR 0.36-2.4) versus C 11% (IQR 7.6-15); and caspase 9, VV 1.7% (IQR 0.06-3.4) versus C 10% (IQR 9.1-12), P=0.0001 (Mann-Whitney test).
CONCLUSION: Apoptosis is down regulated in the medial layer of varicose veins. This dysregulation of the cellular mechanism that maintains normal tissue integrity is mediated through the intrinsic apoptotic pathway and may be among the causes of primary varicose veins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15694809     DOI: 10.1016/j.ejvs.2004.12.012

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  6 in total

1.  Effects of cobalt chloride on phenotypes of normal human saphenous vein smooth muscle cells.

Authors:  Jing Li; Huai-Ming Wang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Functional adaptation of venous smooth muscle response to vasoconstriction in proximal, distal, and varix segments of varicose veins.

Authors:  Joseph D Raffetto; Xiaoying Qiao; Katie G Beauregard; Alain F Tanbe; Abhinav Kumar; Virak Mam; Raouf A Khalil
Journal:  J Vasc Surg       Date:  2010-04       Impact factor: 4.268

3.  Sustained static stress-induced chondrocyte apoptosis in the rat cervical vertebral growth plate and its signal transduction mechanisms.

Authors:  Ming Zhang; Tiansheng Zheng; Min Zong; Dechao Kong; Xiang Li; Cheng Xue; Peng Fu; Jiahu Fang
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-08-20

4.  Increased extrinsic apoptotic pathway activity in patients with hepatocellular carcinoma following transarterial embolization.

Authors:  Shih-Ho Wang; Li-Mien Chen; Wen-Kai Yang; Jane-Dar Lee
Journal:  World J Gastroenterol       Date:  2011-11-14       Impact factor: 5.742

5.  Varicose veins: role of mechanotransduction of venous hypertension.

Authors:  Hussein M Atta
Journal:  Int J Vasc Med       Date:  2012-02-12

Review 6.  The aging venous system: from varicosities to vascular cognitive impairment.

Authors:  Andrea Ágnes Molnár; György László Nádasy; Gabriella Dörnyei; Bernadett Bettina Patai; Jordan Delfavero; Gábor Áron Fülöp; Angelia C Kirkpatrick; Zoltán Ungvári; Béla Merkely
Journal:  Geroscience       Date:  2021-11-11       Impact factor: 7.713

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.